CCND2 and MDM2 amplifications were also significantly more frequent in patients with IBC compared to patients with non-IBC in the primary samples, while DDR2, IKBKE and MDM4 amplifications showed a significant association in the metastases. Here, MDM2 is linked to inflammatory breast carcinoma.